Valeant Fails To Reach $100 On Intra-Day Basis For The First Time Since September 2013
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares are trading lower by $4.23 at $93.63 in Wednesday's session.
Off the open, it failed to reach triple digits on an intra-day basis for the first time since September 13, 2013, when it peaked at $99.50. Since making the high, it has declined to $92.29 and has not been about to mount much of a rally.
There is one daily support level ahead of the low for the recent down move that stands at its October 30 low ($90.46).
Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show.
Do you like this article? Do you have suggestions for improvement? Please email firstname.lastname@example.org
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.